The role of intermediary domain of MyD88 in cell activation and therapeutic inhibition of TLRs

Journal of Immunology

Volumn 187, Issue 5, 2011, Pages 2394-2404

  Avbelj, Monika ^a,b   Horvat, Simon ^a,c   Jerala, Roman ^a,b,c  

^a NATIONAL INSTITUTE OF CHEMISTRY   (Slovenia)

^b EN FIST CENTRE OF EXCELLENCE   (Slovenia)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; ANTENNAPEDIA INT PEPTIDE; ANTIINFLAMMATORY AGENT; BETA INTERFERON; CELL PENETRATING PEPTIDE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; LAURATE INT PEPTIDE; LAURIC ACID; LIPOPOLYSACCHARIDE; MESSENGER RNA; MUTANT PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; MYRISTATE INT PEPTIDE; MYRISTATE INT13 PEPTIDE; MYRISTATE INT17 PEPTIDE; MYRISTATE INT21 PEPTIDE; MYRISTATE INT9 PEPTIDE; MYRISTIC ACID; PEPTIDE DERIVATIVE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ACYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRUCTURE; CELL TRANSPORT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; INFLAMMATORY DISEASE; MESSENGER RNA SYNTHESIS; MOLECULAR MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS INHIBITION; PROTEIN TARGETING; RECEPTOR BLOCKING; TRANSCRIPTION INITIATION;

ANIMALS; BLOTTING, WESTERN; CYTOKINES; FEMALE; HEK293 CELLS; HELA CELLS; HUMANS; INFLAMMATION; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, INTERLEUKIN-1; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 80052688676     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100515     Document Type: Article

References (41)

1. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511. (Pubitemid 38931765)
2. Fitzgerald, K. A., E. M. Palsson-McDermott, A. G. Bowie, C. A. Jefferies, A. S. Mansell, G. Brady, E. Brint, A. Dunne, P. Gray, M. T. Harte, et al. 2001. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413: 78-83. (Pubitemid 32843491)
3. Horng, T., G. M. Barton, and R. Medzhitov. 2001. TIRAP: an adapter molecule in the Toll signaling pathway. Nat. Immunol. 2: 835-841.
4. Fitzgerald, K. A., D. C. Rowe, B. J. Barnes, D. R. Caffrey, A. Visintin, E. Latz, B. Monks, P. M. Pitha, and D. T. Golenbock. 2003. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. J. Exp. Med. 198: 1043-1055. (Pubitemid 37248620)
5. Yamamoto, M., S. Sato, K. Mori, K. Hoshino, O. Takeuchi, K. Takeda, and S. Akira. 2002. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J. Immunol. 169: 6668-6672. (Pubitemid 36899248)
6. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801. (Pubitemid 43261452)
7. Dunne, A., and L. A. O'Neill. 2003. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci. STKE 2003: re3.
8. Medzhitov, R., P. Preston-Hurlburt, E. Kopp, A. Stadlen, C. Chen, S. Ghosh, and C. A. Janeway Jr. 1998. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell 2: 253-258. (Pubitemid 128373651)
9. Ohnishi, H., H. Tochio, Z. Kato, K. E. Orii, A. Li, T. Kimura, H. Hiroaki, N. Kondo, and M. Shirakawa. 2009. Structural basis for the multiple interactions of the MyD88 TIR domain in TLR4 signaling. Proc. Natl. Acad. Sci. USA 106: 10260-10265.
10. Kollewe, C., A. C. Mackensen, D. Neumann, J. Knop, P. Cao, S. Li, H. Wesche, and M. U. Martin. 2004. Sequential autophosphorylation steps in the interleukin-1 receptor-associated kinase-1 regulate its availability as an adapter in interleukin-1 signaling. J. Biol. Chem. 279: 5227-5236. (Pubitemid 38220541)
11. Burns, K., S. Janssens, B. Brissoni, N. Olivos, R. Beyaert, and J. Tschopp. 2003. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J. Exp. Med. 197: 263-268. (Pubitemid 36152320)
12. Janssens, S., K. Burns, J. Tschopp, and R. Beyaert. 2002. Regulation of interleukin-1- and lipopolysaccharide-induced NF-kappaB activation by alternative splicing of MyD88. Curr. Biol. 12: 467-471. (Pubitemid 34248892)
13. Loiarro, M., G. Gallo, N. Fantò, R. De Santis, P. Carminati, V. Ruggiero, and C. Sette. 2009. Identification of critical residues of the MyD88 death domain involved in the recruitment of downstreamkinases. J. Biol. Chem. 284: 28093-28103.
14. Motshwene, P. G., M. C. Moncrieffe, J. G. Grossmann, C. Kao, M. Ayaluru, A. M. Sandercock, C. V. Robinson, E. Latz, and N. J. Gay. 2009. An oligomeric signaling platform formed by the Toll-like receptor signal transducers MyD88 and IRAK-4. J. Biol. Chem. 284: 25404-25411.
15. Burns, K., F. Martinon, C. Esslinger, H. Pahl, P. Schneider, J. L. Bodmer, F. Di Marco, L. French, and J. Tschopp. 1998. MyD88, an adapter protein involved in interleukin-1 signaling. J. Biol. Chem. 273: 12203-12209. (Pubitemid 28240584)
16. Lin, S. C., Y. C. Lo, and H. Wu. 2010. Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature 465: 885-890.
17. Tsujimoto, H., S. Ono, P. A. Efron, P. O. Scumpia, L. L. Moldawer, and H. Mochizuki. 2008. Role of Toll-like receptors in the development of sepsis. Shock 29: 315-321. (Pubitemid 351271701)
18. Sacre, S. M., E. Andreakos, S. Kiriakidis, P. Amjadi, A. Lundberg, G. Giddins, M. Feldmann, F. Brennan, and B. M. Foxwell. 2007. The Toll-like receptor adaptor proteins MyD88 and Mal/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis. Am. J. Pathol. 170: 518-525. (Pubitemid 47339389)
19. Chen, C. J., Y. Shi, A. Hearn, K. Fitzgerald, D. Golenbock, G. Reed, S. Akira, and K. L. Rock. 2006. MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. J. Clin. Invest. 116: 2262-2271. (Pubitemid 44162336)
20. Barrat, F. J., T. Meeker, J. Gregorio, J. H. Chan, S. Uematsu, S. Akira, B. Chang, O. Duramad, and R. L. Coffman. 2005. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J. Exp. Med. 202: 1131-1139. (Pubitemid 41464506)
21. Rakoff-Nahoum, S., L. Hao, and R. Medzhitov. 2006. Role of toll-like receptors in spontaneous commensal-dependent colitis. Immunity 25: 319-329. (Pubitemid 44224143)
22. Rakoff-Nahoum, S., and R. Medzhitov. 2007. Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 317: 124-127. (Pubitemid 47056471)
23. Kleinridders, A., D. Schenten, A. C. Könner, B. F. Belgardt, J. Mauer, T. Okamura, F. T. Wunderlich, R. Medzhitov, and J. C. Brüning. 2009. MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity. Cell Metab. 10: 249v259.
24. Terrando, N., C. Monaco, D. Ma, B. M. Foxwell, M. Feldmann, and M. Maze. 2010. Tumor necrosis factor-alpha triggers a cytokine cascade yielding post-operative cognitive decline. Proc. Natl. Acad. Sci. USA 107: 20518-20522.
25. Loiarro, M., C. Sette, G. Gallo, A. Ciacci, N. Fantò, D. Mastroianni, P. Carminati, and V. Ruggiero. 2005. Peptide-mediated interference of TIR domain dimerization in MyD88 inhibits interleukin-1-dependent activation of NF-kappaB. J. Biol. Chem. 280: 15809-15814. (Pubitemid 40616701)
26. Loiarro, M., F. Capolunghi, N. Fantò, G. Gallo, S. Campo, B. Arseni, R. Carsetti, P. Carminati, R. De Santis, V. Ruggiero, and C. Sette. 2007. Pivotal Advance: Inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound. J. Leukoc. Biol. 82: 801-810. (Pubitemid 47511039)
27. Toshchakov, V. U., S. Basu, M. J. Fenton, and S. N. Vogel. 2005. Differential involvement of BB loops of toll-IL-1 resistance (TIR) domain-containing adapter proteins in TLR4- versus TLR2-mediated signal transduction. J. Immunol. 175: 494-500. (Pubitemid 40884354)
28. Toshchakov, V. Y., M. J. Fenton, and S. N. Vogel. 2007. Cutting edge: Differential inhibition of TLR signaling pathways by cell-permeable peptides representing BB loops of TLRs. J. Immunol. 178: 2655-2660. (Pubitemid 46333141)
29. Lysakova-Devine, T., B. Keogh, B. Harrington, K. Nagpal, A. Halle, D. T. Golenbock, T. Monie, and A. G. Bowie. 2010. Viral inhibitory peptide of TLR4, a peptide derived from vaccinia protein A46, specifically inhibits TLR4 by directly targeting MyD88 adaptor-like and TRIF-related adaptor molecule. J. Immunol. 185: 4261-4271.
30. Kerkis, A., M. A. Hayashi, T. Yamane, and I. Kerkis. 2006. Properties of cell penetrating peptides (CPPs). IUBMB Life 58: 7-13.
31. Liu, X. Y., D. Robinson, R. A. Veach, D. Liu, S. Timmons, R. D. Collins, and J. Hawiger. 2000. Peptide-directed suppression of a pro-inflammatory cytokine response. J. Biol. Chem. 275: 16774-16778. (Pubitemid 30398910)
32. Letoha, T., E. Kusz, G. Pápai, A. Szabolcs, J. Kaszaki, I. Varga, T. Takács, B. Penke, and E. Duda. 2006. In vitro and in vivo nuclear factor-kappaB inhibitory effects of the cell-penetrating penetratin peptide. Mol. Pharmacol. 69: 2027-2036. (Pubitemid 43894322)
33. Nelson, A. R., L. Borland, N. L. Allbritton, and C. E. Sims. 2007. Myristoyl-based transport of peptides into living cells. Biochemistry 46: 14771-14781. (Pubitemid 350308869)
34. Huang, Q., J. Yang, Y. Lin, C. Walker, J. Cheng, Z. G. Liu, and B. Su. 2004. Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3. Nat. Immunol. 5: 98-103. (Pubitemid 38081474)
35. Xiao, T., P. Towb, S. A. Wasserman, and S. R. Sprang. 1999. Three-dimensional structure of a complex between the death domains of Pelle and Tube. Cell 99: 545-555.
36. Mendoza-Barberá, E., M. A. Corral-Rodríguez, A. Soares-Schanoski, M. Velarde, S. Macieira, A. Messerschmidt, E. López-Collazo, and P. Fuentes-Prior. 2009. Contribution of globular death domains and unstructured linkers to MyD88. IRAK-4 heterodimer formation: an explanation for the antagonistic activity of MyD88s. Biochem. Biophys. Res. Commun. 380: 183-187.
37. Prilusky, J., C. E. Felder, T. Zeev-Ben-Mordehai, E. H. Rydberg, O. Man, J. S. Beckmann, I. Silman, and J. L. Sussman. 2005. FoldIndex: a simple tool to predict whether a given protein sequence is intrinsically unfolded. Bioinformatics 21: 3435-3438. (Pubitemid 41222454)
38. Xiao, T., K. H. Gardner, and S. R. Sprang. 2002. Cosolvent-induced transformation of a death domain tertiary structure. Proc. Natl. Acad. Sci. USA 99: 11151-11156. (Pubitemid 34920894)
39. Boussard, G., and M. Marraud. 1985. β-Turns in model dipeptides. An infrared quantitative analysis with NMR correlation. J. Am. Chem. Soc. 107: 1825-1828.
40. Jiang, Z., P. Georgel, C. Li, J. Choe, K. Crozat, S. Rutschmann, X. Du, T. Bigby, S. Mudd, S. Sovath, et al. 2006. Details of Toll-like receptor:adapter interaction revealed by germ-line mutagenesis. Proc. Natl. Acad. Sci. USA 103: 10961-10966. (Pubitemid 44148401)
41. Meier, A., G. Alter, N. Frahm, H. Sidhu, B. Li, A. Bagchi, N. Teigen, H. Streeck, H. J. Stellbrink, J. Hellman, et al. 2007. MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands. J. Virol. 81: 8180-8191. (Pubitemid 47101504)